| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 64 | 64 | 75 | 79 | 71 | 72 | 99 | 95 | 69 | 68 | 74 | 72 | 71 | 88 | 76 | 75 | 65 | 78 | 87 | 107 | 95 | 101 | 103 | 106 | 69 | 87 | 97 | 119 | 83 | 94 | 98 | 110 | 73 | 91 | 110 | 111 |
| Expenses | 57 | 55 | 64 | 62 | 62 | 61 | 85 | 84 | 64 | 63 | 65 | 62 | 60 | 81 | 67 | 65 | 59 | 67 | 76 | 90 | 82 | 87 | 88 | 90 | 63 | 77 | 85 | 102 | 74 | 83 | 85 | 94 | 68 | 83 | 96 | 98 |
| EBITDA | 7 | 9 | 11 | 17 | 9 | 11 | 13 | 11 | 4 | 5 | 9 | 9 | 11 | 8 | 8 | 10 | 7 | 11 | 11 | 16 | 13 | 14 | 16 | 16 | 6 | 11 | 13 | 17 | 9 | 11 | 13 | 16 | 6 | 8 | 15 | 13 |
| Operating Profit % | 11 % | 13 % | 15 % | 13 % | 12 % | 14 % | 13 % | 11 % | 5 % | 7 % | 11 % | 10 % | 15 % | 9 % | 10 % | 12 % | 8 % | 13 % | 12 % | 14 % | 12 % | 12 % | 13 % | 15 % | 7 % | 11 % | 12 % | 13 % | 10 % | 10 % | 12 % | 13 % | 6 % | 6 % | 12 % | 7 % |
| Depreciation | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Interest | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 3 | 4 | 7 | 11 | 4 | 5 | 8 | 5 | -2 | -2 | 2 | 3 | 4 | 1 | 2 | 3 | 0 | 4 | 6 | 11 | 8 | 8 | 10 | 10 | 0 | 5 | 7 | 11 | 1 | 3 | 6 | 8 | -2 | -0 | 6 | 5 |
| Tax | 1 | 1 | 1 | 3 | 0 | 1 | 2 | 3 | -3 | -1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 2 | 4 | 2 | 3 | 3 | 3 | 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | -1 | 0 | 2 | 1 |
| Net Profit | 2 | 3 | 6 | 8 | 4 | 3 | 6 | 2 | 0 | -1 | 2 | 2 | 3 | 1 | 1 | 2 | 0 | 3 | 4 | 7 | 5 | 5 | 7 | 7 | 0 | 4 | 5 | 8 | 1 | 2 | 4 | 5 | -2 | -0 | 4 | 4 |
| EPS in ₹ | 2.66 | 1.79 | 7.81 | 4.84 | 2.35 | 2.08 | 3.65 | 1.43 | 0.05 | -0.37 | 0.94 | 1.41 | 2.02 | 0.73 | 0.80 | 0.95 | 0.12 | 2.00 | 2.51 | 4.33 | 3.17 | 3.35 | 1.35 | 1.48 | 0.05 | 0.85 | 0.98 | 1.66 | 0.18 | 0.49 | 0.82 | 1.01 | -0.38 | -0.09 | 0.90 | 0.76 |
Zim Laboratories
Zim Laboratories
113.62
-2.31
(-1.99%)
Market Cap
608.42 Cr
PE Ratio
104.36
Volume
13,566.00
Day High - Low
113.92 - 113.62
52W High-Low
133.90 - 59.31
There are 3 new updates from the company1 day ago
View
Key Fundamentals
Market Cap
608.42 Cr
EPS
1.19
PE Ratio
104.36
PB Ratio
2.07
Book Value
54.86
EBITDA
41.40
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
1.97
Debt to Equity
0.45
Actual
Company News
View All News
Zim Laboratories Limited has initiated a postal ballot process to seek shareholder approval for revising the remuneration structure of its Managing Director and Whole-Time Director. The remote e-voting period is open from July 13 to August 11, 2026.
Zim Laboratories to meet Tata Asset
10 days ago
10 days agoZim Laboratories Ltd will hold a one-on-one meeting with Tata Asset Management on July 3, 2026. No unpublished price sensitive information will be shared.
Zim Laboratories to meet investors on July 3Jun 30, 2026
Jun 30, 2026Zim Laboratories Ltd scheduled a one-on-one meeting with Tata Asset Management on July 3, 2026. The meeting will be held in person and will not involve sharing unpublished price sensitive information.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,935.50 | #1 4,64,391.28 | 40.42 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 69.33 | |
6,836.00 | 1,81,474.32 | 70.42 | 10,560.00 | 8.73 | 2,520 | 13.44 | 57.88 | |
4,901.50 | 1,65,889.03 | 77.50 | 13,886.20 | 20.34 | 2,138 | -26.91 | 76.03 | |
1,439.40 | 1,16,281.25 | 30.16 | 29,044.60 | 2.24 | 3,870 | -55.32 | 56.29 | |
1,150.80 | 1,15,797.41 | 22.58 | 26,719.70 | 13.65 | 5,242 | 7.82 | 65.75 | |
2,496.30 | 1,14,138.96 | #1 21.37 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 68.54 | |
2,525.10 | 1,04,285.61 | 53.94 | 14,277.60 | 12.03 | 1,750 | 31.75 | 58.02 | |
1,244.30 | 1,03,857.87 | 25.49 | 35,058.60 | 3.90 | 4,158 | -86.05 | 35.49 | |
1,564.70 | 90,029.38 | 26.31 | 33,384.70 | 3.21 | 3,376 | 1.99 | 56.89 | |
1,537.80 | 83,019.15 | 91.21 | 6,867.80 | #1 22.01 | 890 | 21.18 | 64.70 |
Growth Rate
Revenue Growth
0.26 %
Net Income Growth
-52.46 %
Cash Flow Change
20.36 %
ROE
-59.13 %
ROCE
-36.11 %
EBITDA Margin (Avg.)
-16.63 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 265 | 256 | 259 | 298 | 329 | 325 | 325 | 342 | 342 | 447 | 472 | 539 |
| Fixed Assets | 87 | 92 | 89 | 94 | 106 | 116 | 107 | 106 | 109 | 161 | 164 | 162 |
| Current Assets | 168 | 154 | 154 | 173 | 194 | 182 | 192 | 212 | 191 | 228 | 231 | 276 |
| Capital Work in Progress | 6 | 3 | 4 | 8 | 13 | 10 | 11 | 12 | 27 | 42 | 71 | 96 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 172 | 161 | 166 | 196 | 209 | 200 | 208 | 224 | 206 | 244 | 238 | 282 |
| Total Equity & Liabilities | 265 | 256 | 259 | 298 | 329 | 325 | 325 | 342 | 342 | 447 | 472 | 539 |
| Current Liabilities | 133 | 122 | 113 | 141 | 155 | 143 | 142 | 146 | 111 | 159 | 166 | 190 |
| Non Current Liabilities | 38 | 35 | 28 | 20 | 22 | 28 | 22 | 20 | 30 | 49 | 54 | 53 |
| Total Equity | 94 | 99 | 118 | 137 | 151 | 154 | 161 | 176 | 200 | 239 | 252 | 296 |
| Reserve & Surplus | 86 | 91 | 110 | 129 | 135 | 138 | 145 | 160 | 152 | 190 | 202 | 240 |
| Share Capital | 8 | 8 | 8 | 8 | 16 | 16 | 16 | 16 | 49 | 49 | 49 | 54 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -7 | -0 | -0 | 1 | -1 | 1 | -0 | 2 | 3 | 3 | -8 | 23 |
| Investing Activities | -9 | -12 | -7 | -26 | -21 | -19 | -6 | -14 | -35 | -73 | -40 | -55 |
| Operating Activities | 6 | 22 | 32 | 37 | 35 | 22 | 32 | 49 | 38 | 16 | 41 | 50 |
| Financing Activities | -4 | -10 | -25 | -10 | -15 | -2 | -26 | -33 | 1 | 60 | -9 | 28 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 33.26 % | 30.34 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.00 % | 0.00 % | 0.21 % | 0.01 % | 0.03 % | 0.00 % | 0.02 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.11 % | 0.10 % | 0.24 % | 0.24 % | 0.24 % | 0.24 % | 0.20 % | 0.07 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 30.73 % | 51.92 % | 51.96 % | 50.67 % | 50.77 % | 51.15 % | 50.96 % | 51.57 % | 51.57 % | 49.90 % | 50.74 % | 50.92 % | 49.01 % | 49.21 % | 45.48 % | 44.39 % | 47.78 % | 47.50 % | 48.20 % | 36.63 % | 32.77 % |
| Others | 36.01 % | 14.81 % | 14.77 % | 16.06 % | 15.97 % | 15.59 % | 15.78 % | 15.17 % | 15.16 % | 16.84 % | 15.99 % | 15.82 % | 17.72 % | 17.42 % | 21.15 % | 21.90 % | 18.71 % | 18.96 % | 18.30 % | 29.89 % | 36.81 % |
| No of Share Holders | 4,600 | 4,887 | 4,610 | 3,646 | 3,561 | 3,569 | 3,643 | 5,595 | 5,879 | 8,982 | 15,305 | 17,342 | 17,100 | 17,483 | 17,716 | 17,450 | 17,448 | 16,641 | 17,282 | 17,251 | 16,762 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
 Bonus | 1:1 | 04 Oct 2018 | 55.33 | 0.00 | |
| 29 Jun 2022 |  Extraordinary General Meeting | NA | 29 Jun 2022 | 77.67 | 63.50 |
| 22 Dec 2022 | Bonus | 2:1 | 22 Dec 2022 | 105.18 | 110.83 |
| 27 Jun 2024 |  Annual General Meeting | NA | 27 Jun 2024 | 102.30 | 105.00 |
| 09 Nov 2024 |  Quarterly Result Announcement | NA | 09 Nov 2024 | 106.99 | 113.35 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 101.05 | 106.72 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 88.41 | 92.99 |
| 27 Jun 2025 | Annual General Meeting | NA | 27 Jun 2025 | 88.14 | 112.62 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 111.70 | 79.30 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 73.32 | 77.62 |
| 11 Feb 2026 | Quarterly Result Announcement | NA | 11 Feb 2026 | 72.23 | 77.82 |
| 16 Feb 2026 | Extraordinary General Meeting | NA | 16 Feb 2026 | 76.10 | 71.79 |
| 19 May 2026 | Quarterly Result Announcement | NA | 19 May 2026 | 109.29 | 96.00 |
| 29 Jun 2026 | Annual General Meeting | NA | 29 Jun 2026 | 108.80 | 124.90 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication7 hrs ago
7 hrs agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20181 day ago
1 day agoShareholder Meeting / Postal Ballot-Notice of Postal Ballot1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Jun 30, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Jun 30, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 29, 2026
Jun 29, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMJun 29, 2026
Jun 29, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 13, 2026
Jun 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 06, 2026
Jun 06, 2026 Letter Sent To MembersJun 05, 2026
Jun 05, 2026Reg. 34 (1) Annual Report.Jun 05, 2026
Jun 05, 2026The Notice Of 42Nd Annual General Meeting For The F.Y 2025-26Jun 05, 2026
Jun 05, 2026Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jun 05, 2026
Jun 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
May 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2026
May 20, 2026Earnings Presentation Q4 & FY26May 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2026
May 19, 2026Results - Financial Results For 31.03.2026May 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 19, 2026
May 19, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 19.05.2026May 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2026
May 13, 2026Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financial Results For The Year Eneded 31St March 2026.May 12, 2026
May 12, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 08, 2026
May 08, 2026Update - Completion Of EU-GMP Inspection / AuditMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 18, 2026
Apr 18, 2026Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 09, 2026
Apr 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Intimation Of Appointment Of Internal Auditor Of The CompanyMar 30, 2026
Mar 30, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 18, 2026
Mar 18, 2026Announcement Under Regulation 30- Constitution Of Advisory BoardMar 17, 2026
Mar 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-AllotmentMar 13, 2026
Mar 13, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 23, 2026
Feb 23, 2026Announcement under Regulation 30 (LODR)-Credit RatingFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2026
Feb 17, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 16, 2026
Feb 16, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2026
Feb 12, 2026Disclosure Under Regulation- 30Feb 11, 2026
Feb 11, 2026Disclosure Under Regulation- 30Feb 11, 2026
Feb 11, 2026Disclosure Under Regulation 30- Incorporation Of Wholly Owned SubsidiaryFeb 11, 2026
Feb 11, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Tata India Pharma & Healthcare Fund Direct-Growth | 0.49% | 0 | 0.00% | 0.49% |
Technical Indicators
RSI(14)
Neutral 47.04
ATR(14)
Less Volatile 4.84
STOCH(9,6)
Oversold 11.32
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -1.77
ADX(14)
Strong Trend 30.59
UO(9)
Bearish 44.37
ROC(12)
Downtrend And Accelerating -6.71
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
